IBI3009

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI3009, covering 2025-02-11 to 2025-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer [Phase 1]

See pricing